ストックスクリーナーアプリを入手
8.28
4.39%
-0.38
前日終値:
$8.66
開ける：
$8.69
24時間の取引高:
855.24K
Relative Volume:
0.48
時価総額：
$498.31M
収益：
$91.06M
当期純損益:
$-503.14M
株価収益率:
-0.9869
EPS:
-8.39
ネットキャッシュフロー:
$-424.74M
1週間 パフォーマンス:
+2.22%
1か月 パフォーマンス:
+15.16%
6か月 パフォーマンス:
+13.58%
1年 パフォーマンス:
-55.82%
1日の値動き範囲:
$8.235
$8.81
1週間の範囲:
$7.99
$8.81
52週間の値動き範囲:
$4.62
$18.76
Sage Therapeutics Inc Stock (SAGE) Company Profile
SAGE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SAGE
Sage Therapeutics Inc
|
8.28 | 498.31M | 91.06M | -503.14M | -424.74M | -8.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
492.69 | 131.41B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
637.36 | 72.26B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
589.15 | 35.93B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
268.46 | 34.75B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
267.39 | 28.24B | 3.81B | -644.79M | -669.77M | -6.24 |
Sage Therapeutics Inc Stock (SAGE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-11 | 再開されました | BofA Securities | Underperform |
| 2024-11-21 | アップグレード | RBC Capital Mkts | Underperform → Sector Perform |
| 2024-10-10 | 再開されました | Raymond James | Mkt Perform |
| 2024-10-04 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-07-30 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-07-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-05-29 | 開始されました | Citigroup | Sell |
| 2024-05-29 | 開始されました | Robert W. Baird | Neutral |
| 2024-04-17 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-12-12 | 開始されました | Deutsche Bank | Hold |
| 2023-08-08 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2023-08-08 | ダウングレード | Goldman | Buy → Neutral |
| 2023-08-08 | ダウングレード | Needham | Buy → Hold |
| 2023-08-07 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-08-07 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2023-08-07 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-08-07 | ダウングレード | Stifel | Buy → Hold |
| 2023-08-07 | ダウングレード | Wedbush | Outperform → Neutral |
| 2023-07-27 | 開始されました | Scotiabank | Sector Outperform |
| 2023-03-13 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-01-03 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-11-01 | 開始されました | Loop Capital | Hold |
| 2022-03-31 | 開始されました | Berenberg | Hold |
| 2021-11-02 | アップグレード | Guggenheim | Neutral → Buy |
| 2021-10-19 | 再開されました | Morgan Stanley | Equal-Weight |
| 2021-10-07 | ダウングレード | Jefferies | Buy → Hold |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-06-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-04-07 | 開始されました | Piper Sandler | Overweight |
| 2021-02-26 | ダウングレード | Mizuho | Buy → Neutral |
| 2021-02-25 | 繰り返されました | H.C. Wainwright | Neutral |
| 2021-02-02 | 再開されました | Raymond James | Mkt Perform |
| 2021-01-22 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2021-01-04 | アップグレード | Guggenheim | Neutral → Buy |
| 2021-01-04 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-12-04 | アップグレード | Mizuho | Neutral → Buy |
| 2020-12-01 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-11-16 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-11-06 | 繰り返されました | H.C. Wainwright | Neutral |
| 2020-09-11 | アップグレード | Wedbush | Neutral → Outperform |
| 2020-08-10 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-05-08 | ダウングレード | Wedbush | Outperform → Neutral |
| 2020-04-08 | ダウングレード | Guggenheim | Buy → Neutral |
| 2020-03-18 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-06 | 開始されました | Citigroup | Buy |
| 2020-02-28 | 繰り返されました | H.C. Wainwright | Neutral |
| 2020-02-06 | 開始されました | Mizuho | Neutral |
| 2019-12-06 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2019-12-05 | 繰り返されました | Guggenheim | Buy |
| 2019-12-05 | ダウングレード | SunTrust | Buy → Hold |
| 2019-10-30 | 開始されました | H.C. Wainwright | Neutral |
| 2019-05-23 | 開始されました | Wedbush | Outperform |
| 2019-04-25 | 開始されました | Jefferies | Buy |
| 2018-12-14 | 開始されました | Wolfe Research | Outperform |
| 2018-10-11 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Sage Therapeutics Inc (SAGE) 最新ニュース
SAGE THERAPEUTICS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc.SAGE - The Malaysian Reserve
Sage Therapeutics, Inc. (NASDAQ:SAGE) Given Consensus Rating of “Hold” by Analysts - Defense World
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Shareholders to Reach Out - Markets Insider
Status Epilepticus Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight | Marinus Pharma, Pfizer, UCB Biopharma SRL, Sage Therapeutics, Shire - The Globe and Mail
How To Trade (SAGE) - Stock Traders Daily
Bank of New York Mellon Corp Has $931,000 Holdings in Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Investors to Learn More About the Investigation - Markets Insider
Amundi Invests $166,000 in Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World
Investors who hold shares of Sage Therapeutics, Inc. (NASDAQ: - openPR
US Bancorp DE Acquires 2,268 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World
Notice to Long-Term Shareholders of Fluence Energy, Inc. - GlobeNewswire
SAGE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Sage Therapeutics, Inc.SAGE - Business Wire
Sage moved to Underperform at BofA; says Biogen’s buyout impact has passed - MSN
Attention Long-Term Shareholders of Driven Brands Holdings, Inc. (NASDAQ: DRVN); Mercury Systems, Inc. (NASDAQ: MRCY); Playstudios, Inc. (NASDAQ: MYPS); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on You - The Globe and Mail
Notice to Long-Term Shareholders of Mercury Systems, Inc. - GlobeNewswire
Notice to Long-Term Shareholders of Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims - Morningstar
Notice to Long-Term Shareholders of Mercury Systems, Inc. (NASDAQ: MRCY); Methode Electronics, Inc. (NYSE: MEI); Monolithic Power Systems, Inc. (NASDAQ: MPWR); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Behalf - GlobeNewswire Inc.
Long-Term Shareholder Notice: Fluence Energy, Inc. (NASDAQ: - GlobeNewswire
Long-Term Shareholder Notice: Fluence Energy, Inc. (NASDAQ: FLNC); Kyverna Therapuetics, Inc. (NASDAQ: KYTX); Mercury Systems, Inc. (NASDAQ: MRCY); and Sage Therapeutics, Inc. (NASDAQ: SAGE): Grabar Law Office Investigates Claims on Your Be - TradingView
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Long-Term Shareholder Notice: Driven Brands Holdings, Inc. - GlobeNewswire
Sage Therapeutics (NASDAQ:SAGE) Now Covered by Analysts at Bank of America - Defense World
Sage Therapeutics stock rated Underperform at BofA (SAGE) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Encourages Sage Therapeutics, Inc. (SAGE) Investors to Inquire about Securities Investigation - Markets Insider
Sage Therapeutics resumed with an Underperform at BofA - TipRanks
Attention Long-Term Shareholders of Driven Brands Holdings, - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Investors to Reach Out - Markets Insider
SAGE Therapeutics, Inc. to Host Earnings Call - ACCESS Newswire
Intra-Cellular deal, Axsome settlement drive neurological index recovery - BioWorld Online
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Reach Out - Markets Insider
Sage’s medical chief is latest leader to leave biotech - The Business Journals
Sage Therapeutics CMO to leave for new opportunity By Investing.com - Investing.com Canada
Sage Therapeutics Announces R&D Leadership Transition - citybiz
Sage Therapeutics announces CMO resignation By Investing.com - Investing.com South Africa
Sage Therapeutics announces CMO resignation - Investing.com
SAGE Therapeutics Announces CMO Resignation and Interim Appointment - TipRanks
SAGE Therapeutics Announces Research And Development Leadership Transition -March 04, 2025 at 04:49 pm EST - Marketscreener.com
Sage Therapeutics CMO to leave for new opportunity - Investing.com
SAGE Therapeutics (SAGE) Announces R&D Leadership Transition - StreetInsider.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Connect - Markets Insider
Levi & Korsinsky Notifies Sage Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSAGE - accessnewswire.com
Levi & Korsinsky Reminds Sage Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – SAGE - ACCESS Newswire
Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
Sage Therapeutics, Inc. (SAGE): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
Biogen proposes acquisition of partner Sage Therapeutics - MSN
Levi & Korsinsky Notifies Shareholders of Sage Therapeutics, Inc.(SAGE) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Shareholders that Lost Money on Sage Therapeutics, Inc. (SAGE) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
12 Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
Shareholders that lost money on Sage Therapeutics, Inc.(SAGE) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
SAGE SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Sage Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Sage Therapeutics Inc (SAGE) 財務データ
収益
当期純利益
現金流量
EPS
0.39%
0.34%
大文字化:
|
ボリューム (24 時間):